Mino-Lok solution for central line infections
Part of Infections clinical trials.
This trial provides access to Mino-Lok Therapy, a special antibiotic solution that is put into the central line to clear infections without removing the line. It is for people with bloodstream infections that come from the line and who can keep the line in place.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years old or older.
- You must have a bloodstream infection with no other source except the central line.
- You should be able to keep the central line in place for the treatment.
- You cannot be allergic to tetracycline antibiotics or edetate disodium.
- You cannot be taking disulfiram, a medicine for alcohol dependence.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to better treat central line infections that are hard to cure because of bacteria that stick to the tube. It may help find a treatment that works better for patients in intensive care.
This study looks at the bacteria that can build up on IV lines to see if they increase the risk of infection. By examining these bacteria, researchers hope to find ways to reduce infections in patients who need IV treatment.
This study tests whether putting a small cap containing chlorhexidine (a germ-killing medicine) on the end of the dialysis catheter can prevent serious bloodstream infections. If you are on dialysis with a catheter, this may help reduce your risk of infection.
This study tests a catheter lock solution called DefenCath (taurolidine and heparin) against a standard heparin lock to see if it reduces central line bloodstream infections in people receiving IV nutrition (total parenteral nutrition) for more than 3 months.
This study aims to reduce infections that can happen when you have a central line, which is a special tube placed in a large vein to give medicines or fluids. It will test ways to improve care for patients with these lines to prevent infections.
This study tests a special fluid used to flush the catheter (called a 'lock') to see if it can prevent infections in newborns. If your baby has a central line, this could help reduce the risk of serious infections.
Hear when a new Catheter-Related Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.